Voskaridou, E., & Terpos, E. (2004). New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. British Journal of Haematology, 127(2), 127–139.
Article PubMed CAS Google Scholar
Karimi, M., Ghiam, A. F., Hashemi, A., Alinejad, S., Soweid, M., & Kashef, S. (2007). Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatrics, 44(1), 29–32.
Mahachoklertwattana, P., Chuansumrit, A., Sirisriro, R., Choubtum, L., Sriphrapradang, A., & Rajatanavin, R. (2003). Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clinical Endocrinology—Oxford, 58(3), 273–279.
Article PubMed CAS Google Scholar
Rund, D., & Rachmilewitz, E. (2005). Beta-thalassemia. New England Journal of Medicine, 353(11), 1135–1146.
Article PubMed CAS Google Scholar
Bielinski, B. K., Darbyshire, P., Mathers, L., Boivin, C. M., & Shaw, N. J. (2001). Bone density in the Asian thalassaemic population: A cross-sectional review. Acta Paediatrica, 90(11), 1262–1266.
Article PubMed CAS Google Scholar
Arjmandi Rafsanjani, K., Razzaghy-Azar, M., Zahedi-Shoolami, L., Vossough, P., Modarres, A., & Taheri, N. (2009). Bone mineral density in β thalassemia major and intermedia, correlation with biochemical and hormonal profiles. IJBC, 1(4), 121–127.
Filosa, A., Di Maio, S., Vocca, S., Saviano, A., Esposito, G., & Pagano, L. (1997). Longitudinal monitoring of bone mineral density in thalassemic patients Genetic structure and osteoporosis. Acta Paediatrica, 86(4), 342–346.
Article PubMed CAS Google Scholar
El-Edel, R. H., Ghonaim, M. M., Abo-Salem, O. M., & El-Nemr, F. M. (2010). Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major. Pakistan Journal of Pharmaceutical Sciences., 23(1), 89–96.
Di Stefano, M., Chiabotto, P., Roggia, C., Garofalo, F., Lala, R., Piga, A., & Isaia, G. C. (2004). Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. Journal of Bone and Mineral Metabolism, 22(1), 53–57.
Dede, A. D., Trovas, G., Chronopoulos, E., Triantafyllopoulos, I. K., Dontas, I., Papaioannou, N., & Tournis, S. (2016). Thalassemia-associated osteoporosis: A systematic review on treatment and brief overview of the disease. Osteoporosis International, 27, 3409–3425.
Article PubMed CAS Google Scholar
Skordis, N., Efstathiou, E., Kyriakou, A., & Toumba, M. (2008). Hormonal dysregulation and bones in thalassaemia–an overview. Pediatric Endocrinology Reviews, 6(Suppl 1), 107–115. PMID: 19337163.
Dines, D. M., Canale, V. C., & Arnold, W. D. (1976). Fractures in thalassemia. Journal of Bone and Joint Surgery. American Volume, 58(5), 662–666.
Toumba, M., & Skordis, N. (2010). Osteoporosis syndrome in thalassaemia major: An overview. Journal of Osteoporosis, 26(2010), 537673.
Joshi, R., & Phatarpekar, A. (2013). Endocrine abnormalities in children with Beta thalassaemia major. Sri Lanka Journal of Child Health, 42(2), 81–86.
De Sanctis V, Soliman AT, Elsedfy H, Yassin M, Canatan D, Kilinc Y, Sobti P, Skordis N, Karimi M, Raiola G, Galati MC, Bedair E, Fiscina B, El Kholy M; I-CET (International Network on Growth Disorders and Endocrine Complications in Thalassemia). Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev. 2013 Dec;11(2):167–80.
Katz, K., Horev, G., Goshen, J., & Tamary, H. (1994). The pattern of bone disease in transfusion-dependent thalassemia major patients. Israel Journal of Medical Sciences, 30(8), 577–580.
Yagizi A, Maalouf G, Inati-khoriati A, Tamim H, Saab c. Bone mineral density in beta thalassemia Lebanese children. J Musculoskeletal Neuron interact. 2002; 2:463–8
Saffari F, Mahyar A, Jalilolgadr S. Endocrine and metabolic disorders in β-thalassemia major patients. Caspian J Intern Med. 2012 Summer; 3(3):466–72.
Merchant, R., Udani, A., Puri, V., D’cruz, V., Patkar, D., & Karkera, A. (2010). Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices. Indian Journal of Pediatrics, 77(9), 987–991.
Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M. Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major. Hormones (Athens). 2007 Oct-Dec;6(4):334–40.
Jeney, V. (2017). Clinical impact and cellular mechanisms of iron overload-associated bone loss. Frontiers in Pharmacology, 21(8), 77.
Rossi, F., Perrotta, S., Bellini, G., Luongo, L., Tortora, C., Siniscalco, D., Francese, M., Torella, M., Nobili, B., Di Marzo, V., & Maione, S. (2014). Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels. Haematologica, 99(12), 1876–1884.
Article PubMed PubMed Central Google Scholar
Casale, M., Citarella, S., Filosa, A., De Michele, E., Palmieri, F., Ragozzino, A., Amendola, G., Pugliese, U., Tartaglione, I., Della Rocca, F., Cinque, P., Nobili, B., & Perrotta, S. (2014). Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. American Journal of Hematology, 89(12), 1102–1106.
Article PubMed CAS Google Scholar
El-Edel, R. H., Ghonaim, M. M., Abo-Salem, O. M., & El-Nemr, F. M. (2010). Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major. Pakistan Journal of Pharmaceutical Sciences, 23(1), 89–96.
Haidar, R., Musallam, K. M., & Taher, A. T. (2011). Bone disease and skeletal complications in patients with β thalassemia major. Bone, 48(3), 425–432.
Comments (0)